482 related articles for article (PubMed ID: 11655783)
41. Minutes of meetings, 31 Jul 1990 16 Oct 1990.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1991; 2(2):177-91. PubMed ID: 11642903
[No Abstract] [Full Text] [Related]
42. Human Gene Therapy Subcommittee: minutes of meeting, 5 Apr 1991.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee
Hum Gene Ther; 1992 Apr; 3(2):233-48. PubMed ID: 11643022
[No Abstract] [Full Text] [Related]
43. Genetic engineering and related biotechnologies: scientific progress and public policy.
Perpich JG
Technol Soc; 1983; 5(1):27-49. PubMed ID: 11650684
[No Abstract] [Full Text] [Related]
44. Genetic experiment by military approved.
Cohn V; Hilts PJ
Washington Post; 1984 Feb; ():A1, A7. PubMed ID: 11646347
[No Abstract] [Full Text] [Related]
45. Minutes of meeting of the Human Gene Therapy Subcommittee, 30 Mar 1990.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee. Human Gene Therapy Subcommitttee
Hum Gene Ther; 1990; 1(4):481-91. PubMed ID: 11642815
[No Abstract] [Full Text] [Related]
46. NIH guidelines for research involving recombinant DNA molecules.
Wilson DJ
Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
[No Abstract] [Full Text] [Related]
47. Battle lines drawn over DNA research.
Joyce C
New Sci; 1983 Sep; 99(1377):912. PubMed ID: 11655568
[No Abstract] [Full Text] [Related]
48. Guide to planning human gene therapy.
Miller JA
Sci News; 1985 Feb; 127(5):71. PubMed ID: 11653569
[No Abstract] [Full Text] [Related]
49. Minutes of meeting, 4 Feb 1991.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1991; 2(4):397-413. PubMed ID: 11642961
[No Abstract] [Full Text] [Related]
50. Gene-splice approvals on two fronts.
Miller JA
Sci News; 1985 Nov; 128(21):324. PubMed ID: 11653676
[No Abstract] [Full Text] [Related]
51. The social warp of science: writing the history of genetic engineering policy.
Wright S
Sci Technol Human Values; 1993; 18(1):79-101. PubMed ID: 11652076
[No Abstract] [Full Text] [Related]
52. Petition to amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to establish a Public Policy Advisory Committee. Foundation on Economic Trends, September 18, 1990.
Hum Gene Ther; 1991; 2(2):131-4. PubMed ID: 1911933
[No Abstract] [Full Text] [Related]
53. Of mice and medicine: balancing scientific needs and animal welfare.
Iglehart JK
Washington Post; 1985 Sep; ():Health Su-15. PubMed ID: 11647799
[No Abstract] [Full Text] [Related]
54. Minutes of meeting, 30-31 May 1991.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1992 Feb; 3(1):95-121. PubMed ID: 11642989
[No Abstract] [Full Text] [Related]
55. A shepherd for transgenic animals.
Connor S
New Sci; 1989 Jan; 121(1648):25. PubMed ID: 11655927
[No Abstract] [Full Text] [Related]
56. Conflict at the RAC.
Culliton BJ
Science; 1990 Apr; 298(4952):159. PubMed ID: 11653881
[No Abstract] [Full Text] [Related]
57. Animal rights and wrongs.
Stryker J
Healthscan; 1984; 1(3):3-10. PubMed ID: 11658711
[No Abstract] [Full Text] [Related]
58. Recombinant DNA Advisory Committee: minutes of meeting, 10-11 Feb 1992.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1992 Oct; 3(5):563-91. PubMed ID: 11643034
[No Abstract] [Full Text] [Related]
59. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
Krimsky S
Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
[No Abstract] [Full Text] [Related]
60. Gene therapy: correcting the errors in life's blueprint.
Merz B
Med World News; 1984 Oct; 25(19):46-52, 55+. PubMed ID: 11645531
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
